Primary aldosteronism concurrent with subclinical Cushing’s syndrome: a case report and review of the literature

[1] Funder JW(2016)The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline J Clin Endocrinol Metab 101 1889-1916

[2] Carey RM(2010)Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined J Clin Endocrinol Metab 95 2618-2620

[3] Mantero F(2017)Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series Endocrine 58 503-512

[4] Murad MH(2003)A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone Intern Med 42 714-718

[5] Reincke M(2001)Combined primary aldosteronism and preclinical Cushing’s syndrome: an unusual case presentation of adrenal adenoma Hypertens Res 24 723-726

[6] Shibata H(2001)A case of aldosterone-producing adrenocortical adenoma associated with preclinical Cushing’s syndrome and hypersecretion of parathyroid hormone Endocr J 48 103-111

[7] Stowasser M(2002)Variant of pre-clinical Cushing’s syndrome: hypertension and hypokalemia associated with normoreninemic normoaldosteronism Hypertens Res 25 623-630

[8] Young WF(1977)Concurrent hypercortisolism and hypermineralocorticoidism Am J Med 62 777-782

[9] Stewart PM(2011)Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome Endocr J 58 543-551

[10] Fallo F(2015)Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion Endocrinol Diabetes Metab Case Rep 2015 150075-undefined

[1] Funder JW(2016)The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline J Clin Endocrinol Metab 101 1889-1916

[2] Carey RM(2010)Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined J Clin Endocrinol Metab 95 2618-2620

[3] Mantero F(2017)Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series Endocrine 58 503-512

[4] Murad MH(2003)A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone Intern Med 42 714-718

[5] Reincke M(2001)Combined primary aldosteronism and preclinical Cushing’s syndrome: an unusual case presentation of adrenal adenoma Hypertens Res 24 723-726

[6] Shibata H(2001)A case of aldosterone-producing adrenocortical adenoma associated with preclinical Cushing’s syndrome and hypersecretion of parathyroid hormone Endocr J 48 103-111

[7] Stowasser M(2002)Variant of pre-clinical Cushing’s syndrome: hypertension and hypokalemia associated with normoreninemic normoaldosteronism Hypertens Res 25 623-630

[8] Young WF(1977)Concurrent hypercortisolism and hypermineralocorticoidism Am J Med 62 777-782

[9] Stewart PM(2011)Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome Endocr J 58 543-551

[10] Fallo F(2015)Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion Endocrinol Diabetes Metab Case Rep 2015 150075-undefined